{"id":57515,"date":"2024-02-27T17:47:54","date_gmt":"2024-02-27T17:47:54","guid":{"rendered":"https:\/\/medsname.com\/hyros\/"},"modified":"2026-05-01T10:49:14","modified_gmt":"2026-05-01T10:49:14","slug":"hyros","status":"publish","type":"product","link":"https:\/\/medsbase.com\/ro\/product\/hyros\/","title":{"rendered":"Hyros"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background:#fff8e1;border-left:4px solid #f5a623;padding:18px 22px;margin:0 0 24px 0;border-radius:4px;\">\n<h3 class=\"wp-block-heading\" style=\"margin:0 0 8px 0;font-size:16px;font-weight:700;\">\u26a1 R\u0103spuns rapid \u2014 Ce este Hyros?<\/h3>\n<p style=\"margin:0;\"><strong>Hyros<\/strong> este un <strong>Comprimat de hydrochlorotiazid\u0103 12,5 \/ 25 mg<\/strong> de la Zydus Cadila \u2014 un <strong>diuretic tiazidic (benzotiadiazin\u0103 sulfonamid\u0103)<\/strong> care ac\u021bioneaz\u0103 asupra <strong>NCC (cotransportor de sodiu-clorur\u0103) \u00een tubul contort distal<\/strong>. Hidroclorotiazida a fost introdus\u0103 \u00een 1959 de Merck Sharp &amp; Dohme sub denumirea <strong>HydroDiuril<\/strong> \u2014 derivat\u0103 din sulfanilamid\u0103 \u00een timpul programului de antibiotice sulfonamide, c\u00e2nd activitatea sa diuretic\u0103 a fost observat\u0103 \u00eent\u00e2mpl\u0103tor. HCTZ a devenit tiazidul de referin\u021b\u0103 \u0219i a r\u0103mas un antihipertensiv de prim\u0103 linie de atunci. Timp de \u00eenjum\u0103t\u0103\u021bire: 6-15 ore; debut: 2 ore; efect maxim: 4-6 ore; durat\u0103: 6-12 ore. Indica\u021bie principal\u0103: <strong>hipertensiune arterial\u0103 (de prim\u0103 linie; recomandat\u0103 \u00een ghiduri al\u0103turi de ARB, ACEi \u0219i CCB)<\/strong>. Dozaj tipic: \u00cencepe\u021bi cu 12,5 mg o dat\u0103 pe zi diminea\u021ba. \u021aint\u0103: 12,5-25 mg. <strong>Nu dep\u0103\u0219i\u021bi 25 mg<\/strong> pentru hipertensiune \u2014 doze mai mari ofer\u0103 randamente descresc\u0103toare asupra TA dar agraveaz\u0103 efectele metabolice adverse (urat, glucoz\u0103, lipide). Ghidurile moderne s-au \u00eendep\u0103rtat de doza istoric\u0103 de 50 mg pentru hipertensiune. Contraindica\u021bii cheie: vede\u021bi lista complet\u0103 mai jos. Monitoriza\u021bi electroli\u021bii, creatinina \u0219i glucoza. <strong>Nu combina\u021bi cu litiu<\/strong> (diureticele tiazidice\/de ans\u0103 pot precipita toxicitatea litiului). <strong>Utilizarea \u00een sarcin\u0103 este specific\u0103 cazului<\/strong> (consulta\u021bi nota despre sarcin\u0103). Pentru majoritatea pacien\u021bilor hipertensivi, diureticele func\u021bioneaz\u0103 cel mai bine ca <strong>al doilea sau al treilea agent<\/strong> \u2014 de obicei combinat cu un BRA, inhibitor ACE sau blocant al canalelor de calciu, mai degrab\u0103 dec\u00e2t utilizat singur.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f4f8fb;border:1px solid #d8e3eb;padding:12px 16px;margin:16px 0;border-radius:4px;font-size:14px;\">\n<strong>Ce beneficii ofer\u0103 MedsBase:<\/strong> Produc\u0103tor certificat WHO-GMP \u00b7 Ambalaj discret \u00b7 Livrare la nivel mondial \u00b7 Peste 1.400 de recenzii verificate <a href=\"https:\/\/medsbase.com\/ro\/reviews\/\">ale clien\u021bilor<\/a>\n<\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size:14px;color:#444;margin:8px 0 18px;\">\ud83d\udce6 Fiecare comand\u0103 este acoperit\u0103 de politica noastr\u0103 de <a href=\"https:\/\/medsbase.com\/ro\/medsbase-re-shipment-assurance-policy\/\"><strong>Politica noastr\u0103 de Reexpediere Garantat\u0103<\/strong><\/a> \u2014 dac\u0103 coletul dumneavoastr\u0103 nu sose\u0219te \u00een 20 de zile lucr\u0103toare, \u00eel relivr\u0103m.<\/p>\n<h3>De ce s\u0103 comanzi de la MedsBase<\/h3>\n<p>Medicamentele noastre generice sunt procurate de la produc\u0103tori certifica\u021bi WHO-GMP \u0219i expediate la nivel mondial \u00een ambalaje discrete \u0219i simple \u2014 f\u0103r\u0103 denumirea medicamentului pe exteriorul coletului. Pl\u0103\u021bile cu cardul sunt procesate printr-un procesor reglementat (descrierile de pe extrasul de cont includ un procesor de pl\u0103\u021bi cu card reglementat \u2014 niciodat\u0103 \u201cMedsBase\u201d sau numele vreunui medicament). Accept\u0103m \u0219i criptomonede \u0219i transferuri bancare SEPA. Fiecare comand\u0103 este sus\u021binut\u0103 de Politica noastr\u0103 de Asigurare pentru Relivrare.<\/p>\n<h2 class=\"wp-block-heading\">Ce este Hyros?<\/h2>\n<p>Hyros este un comprimat oral de hydrochlorotiazid\u0103 12,5\/25 mg de la Zydus Cadila, furnizat \u00een cutii de 30-180 comprimate. Hidroclorotiazida a fost introdus\u0103 \u00een 1959 de Merck Sharp &amp; Dohme ca <strong>HydroDiuril<\/strong> \u2014 derivat din sulfanilamid\u0103 \u00een cadrul programului de antibiotice sulfonamide, c\u00e2nd activitatea sa diuretic\u0103 a fost observat\u0103 \u00eent\u00e2mpl\u0103tor. HCTZ a devenit tiazida de referin\u021b\u0103 \u0219i a r\u0103mas un antihipertensiv de prim\u0103 linie de atunci.<\/p>\n<h2 class=\"wp-block-heading\">Cum func\u021bioneaz\u0103 Hidroclorotiazida<\/h2>\n<p>Hidroclorotiazida inhib\u0103 <strong>NCC (cotransportor de sodiu-clorur\u0103) \u00een tubul contort distal<\/strong>. Efectele secundare:<\/p>\n<ul>\n<li><strong>Reabsorb\u021bia redus\u0103 de sodiu<\/strong> \u00een tubul contort distal \u2014 o cre\u0219tere moderat\u0103 (~5%) a excre\u021biei urinare de sodiu<\/li>\n<li><strong>Contrac\u021bia volumului<\/strong> \u00een primele 1-2 s\u0103pt\u0103m\u00e2ni \u2014 acesta este principalul mecanism de sc\u0103dere a tensiunii arteriale \u00een faza ini\u021bial\u0103<\/li>\n<li><strong>Activitate vasodilatatoare direct\u0103<\/strong> dezvolt\u00e2ndu-se \u00een 2-6 s\u0103pt\u0103m\u00e2ni \u2014 mecanismul dominant pe termen lung de sc\u0103dere a TA; tiazidele \u00een stare stabil\u0103 reduc rezisten\u021ba vascular\u0103 sistemic\u0103 independent de contrac\u021bia continu\u0103 a volumului<\/li>\n<li><strong>Reabsorb\u021bia crescut\u0103 de calciu \u00een tubul distal<\/strong> \u2014 cre\u0219te moderat calciul seric \u0219i reduce calciul urinar (utilizat \u00een preven\u021bia calculilor de calciu)<\/li>\n<li><strong>Reducerea clearance-ului de ap\u0103 liber\u0103<\/strong> \u2014 poate provoca hiponatremie la pacien\u021bii susceptibili<\/li>\n<li><strong>Activarea sistemului renin\u0103-angiotensin\u0103-aldosteron<\/strong> ca r\u0103spuns compensatoriu \u2014 atenueaz\u0103 par\u021bial efectul asupra tensiunii arteriale al monoterapiei; neutralizat prin combinarea cu un ARB sau inhibitor ACE (motiva\u021bia pentru FDC precum <a href=\"https:\/\/medsbase.com\/ro\/telma-h\/\">Telma H<\/a>, <a href=\"https:\/\/medsbase.com\/ro\/cosart-h\/\">Cosart H<\/a>)<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Utiliz\u0103ri aprobate \u0219i bazate pe dovezi<\/h2>\n<ul>\n<li><strong>Hipertensiune arterial\u0103 (de prim\u0103 inten\u021bie; recomandat\u0103 \u00een ghiduri al\u0103turi de ARB, inhibitori ACE \u0219i CCB)<\/strong> \u2014 indica\u021bie principal\u0103<\/li>\n<li><strong>Edem \u00een insuficien\u021b\u0103 cardiac\u0103 u\u0219oar\u0103<\/strong> \u2014 trecere la diuretic de ans\u0103 dac\u0103 nu este controlat<\/li>\n<li><strong>Pietre renale recurente cu con\u021binut de calciu<\/strong> \u2014 doze de 12,5-25 mg reduc excre\u021bia de calciu \u0219i recuren\u021ba pietrelor cu 30-50%<\/li>\n<li><strong>Diabet insipid nefrogen<\/strong> \u2014 reducere paradoxal\u0103 a debitului urinar la 25 mg de dou\u0103 ori pe zi<\/li>\n<li><strong>Osteoporoz\u0103<\/strong> \u2014 beneficiu modest prin reducerea pierderii de calciu \u00een urin\u0103 (doar adjunctiv)<\/li>\n<\/ul>\n<p><strong>Dovezile din studiile pivotale:<\/strong> <strong>ALLHAT (2002)<\/strong> \u2014 chlortalidona (un analog apropiat al tiazidelor) nu a fost inferioar\u0103 amlodipinei \u0219i lisinoprilului pentru evenimente cardiovasculare fatale \u0219i nefatale la peste 33.000 de pacien\u021bi hipertensivi; a consolidat pozi\u021bia tiazidelor ca op\u021biune de prim\u0103 inten\u021bie. <strong>SHEP (1991)<\/strong> \u2014 terapia bazat\u0103 pe chlortalidon\u0103 a redus accidentul vascular cerebral cu 36% la hipertensiunea sistolic\u0103 izolat\u0103 la v\u00e2rstnici. <strong>MRFIT, HDFP<\/strong> (ani 1970-1980) \u2014 baz\u0103 de dovezi anterioar\u0103. Datele la scar\u0103 larg\u0103 cu rezultate concrete specifice HCTZ sunt mai slabe dec\u00e2t cele pentru chlortalidon\u0103, dar se presupune un efect de clas\u0103.<\/p>\n<h2 class=\"wp-block-heading\">Doza Hyros<\/h2>\n<p><strong>Doza pentru hipertensiune:<\/strong> \u00cencepe\u021bi cu 12,5 mg o dat\u0103 pe zi diminea\u021ba. \u021aint\u0103: 12,5-25 mg. <strong>Nu dep\u0103\u0219i\u021bi 25 mg<\/strong> pentru hipertensiune \u2014 dozele mai mari ofer\u0103 randamente descresc\u0103toare asupra TA, dar agraveaz\u0103 efectele secundare metabolice (urat, glucoz\u0103, lipide). Ghidurile moderne s-au \u00eendep\u0103rtat de doza antihipertensiv\u0103 istoric\u0103 de 50 mg.<\/p>\n<p><strong>Alte indica\u021bii:<\/strong> <strong>Edem \u00een insuficien\u021b\u0103 cardiac\u0103 u\u0219oar\u0103:<\/strong> 25-50 mg\/zi; trece\u021bi la un diuretic de ans\u0103 (furosemid\u0103) dac\u0103 nu se controleaz\u0103. <strong>Hipercalciurie idiopatic\u0103 (pietre recurente de calciu):<\/strong> 12,5-25 mg\/zi \u2014 tiazidele promoveaz\u0103 reabsorb\u021bia distal\u0103 de calciu \u0219i reduc recuren\u021ba pietrelor cu 30-50%. <strong>Diabet insipid nefrogenic:<\/strong> 25 mg de dou\u0103 ori pe zi reduce paradoxal produc\u021bia de urin\u0103.<\/p>\n<p><strong>Administrare:<\/strong> o dat\u0103 pe zi (sau de dou\u0103 ori pe zi pentru doze mari de diuretice de ans\u0103 \u00een insuficien\u021b\u0103 cardiac\u0103), diminea\u021ba. Administrarea seara provoac\u0103 nicturie \u0219i ar trebui evitat\u0103 c\u00e2nd este posibil. Lua\u021bi la aceea\u0219i or\u0103 \u00een fiecare zi. Alimenta\u021bia nu afecteaz\u0103 semnificativ absorb\u021bia pentru niciunul dintre aceste diuretice.<\/p>\n<p><strong>Program de monitorizare:<\/strong><\/p>\n<ul>\n<li><strong>Valori ini\u021biale:<\/strong> uree, electroli\u021bi (\u00een special potasiu \u0219i sodiu), creatinin\u0103, eGFR, glucoz\u0103, acid uric seric. Tensiunea arterial\u0103 acas\u0103 sau \u00een clinic\u0103 \u0219i greutatea zilnic\u0103 pentru pacien\u021bii cu insuficien\u021b\u0103 cardiac\u0103.<\/li>\n<li><strong>la 1-2 s\u0103pt\u0103m\u00e2ni dup\u0103 \u00eenceperea sau modificarea dozei:<\/strong> repetarea electroli\u021bilor \u0219i a creatininei. A\u0219tepta\u021bi modific\u0103ri minore ale electroli\u021bilor; investiga\u021bi modific\u0103ri substan\u021biale.<\/li>\n<li><strong>4-6 s\u0103pt\u0103m\u00e2ni:<\/strong> evaluarea tensiunii arteriale \u0219i panelul metabolic complet.<\/li>\n<li><strong>Continuu:<\/strong> electroli\u021bi anuali, acid uric, glucoz\u0103 \u0219i panel lipidic odat\u0103 stabilizat. Mai frecvent \u00een insuficien\u021b\u0103 renal\u0103 cronic\u0103, insuficien\u021b\u0103 cardiac\u0103 sau la terapie combinat\u0103.<\/li>\n<li><strong>\u00centrerupe\u021bi sau reduce\u021bi doza la:<\/strong> sodiu &lt;130 cu simptome, potasiu 5,5, cre\u0219tere creatinin\u0103 &gt;30%, gut\u0103 nou\u0103, simptome severe de deshidratare.<\/li>\n<\/ul>\n<p><strong>\u00centrerupere:<\/strong> nu exist\u0103 sindrom de sevraj, dar \u00eentreruperea brusc\u0103 poate provoca reten\u021bie de volum de tip rebound la pacien\u021bii cu IC sub doze cronice mari de diuretice de ans\u0103 \u2014 reduce\u021bi progresiv doza acolo unde este posibil \u0219i monitoriza\u021bi greutatea.<\/p>\n<ul>\n<li><strong>Pierde eficacitatea la TFG &lt;30.<\/strong> Trece\u021bi la un diuretic de ans\u0103 (furosemid\u0103, torasemid\u0103) \u00een stadiile avansate ale BCR \u2014 tiazidele necesit\u0103 livrare func\u021bional\u0103 de sodiu la nivel tubular distal.<\/li>\n<li><strong>Cre\u0219te calciul seric<\/strong> (paradoxal: tiazidele sporesc reabsorb\u021bia distal\u0103 de calciu). Util la pacien\u021bii cu osteoporoz\u0103; problematic \u00een afec\u021biunile hipercalcemice (hiperparatiroidism primar, sarcoidoz\u0103).<\/li>\n<li><strong>Erup\u021bie fotosensibil\u0103<\/strong> este un efect specific clasei tiazidice \u2014 recomanda\u021bi protec\u021bie solar\u0103 \u00een regiunile \u00eensorite.<\/li>\n<li><strong>Reactivitate cruz\u0103 cu sulfonamide<\/strong> \u2014 evita\u021bi \u00een caz de alergie sever\u0103 la sulfa (rar\u0103; sulfonamidele non-antibiotice rareori au reactivitate cruz\u0103).<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Efecte Secundare<\/h2>\n<p><strong>Frecvente (&gt;1%):<\/strong><\/p>\n<ul>\n<li><strong>Hipokaliemie<\/strong> (3-5%) \u2014 mai frecvent la doze &gt;25 mg; \u00een mare parte prevenit atunci c\u00e2nd este combinat cu un inhibitor ACE\/ARB<\/li>\n<li><strong>Hiponatremie<\/strong> (2-5%) \u2014 mai ales la femeile \u00een v\u00e2rst\u0103 cu diete s\u0103race \u00een sare; poate fi sever<\/li>\n<li><strong>Hiperuricemie<\/strong> \u0219i precipita\u021bia gutei<\/li>\n<li><strong>\u00cenr\u0103ut\u0103\u021bire moderat\u0103 a toleran\u021bei la glucoz\u0103<\/strong> (glicemia la stomac gol +5-8 mg\/dL \u00een medie)<\/li>\n<li><strong>U\u0219oar\u0103 cre\u0219tere a LDL \u0219i trigliceridelor<\/strong><\/li>\n<li><strong>Disfunc\u021bie erectil\u0103<\/strong> la unii b\u0103rba\u021bi \u2014 dependent de doz\u0103<\/li>\n<li><strong>Hipercalcemia<\/strong> (de obicei u\u0219oar\u0103)<\/li>\n<li><strong>Erup\u021bie fotosensibil\u0103<\/strong><\/li>\n<\/ul>\n<p><strong>Pu\u021bin frecvente, dar clinic importante:<\/strong><\/p>\n<ul>\n<li><strong>Hiponatremie sever\u0103<\/strong> \u2014 \u00een special la persoanele \u00een v\u00e2rst\u0103 cu diete s\u0103race \u00een sare, st\u0103ri predispuse la SIADH sau \u00een combina\u021bie cu SSRI. Se poate manifesta prin confuzie, c\u0103deri sau convulsii.<\/li>\n<li><strong>Pancreatit\u0103<\/strong> \u2014 efect rar al clasei de tiazide\/loop; \u00eentrerupe\u021bi imediat la apari\u021bia durerii abdominale superioare cu cre\u0219tere a lipazei<\/li>\n<li><strong>Trombocitopenie, leucopenie, agranulocitoz\u0103<\/strong> \u2014 reac\u021bii rare de hipersensibilitate (mai frecvente la tiazide dec\u00e2t la diureticele de ans\u0103)<\/li>\n<li><strong>Miopie acut\u0103 \u0219i glaucom cu unghi \u00eenchis<\/strong> \u2014 reac\u021bie rar\u0103 din clasa sulfonamidelor, care apare \u00een c\u00e2teva ore sau zile de la \u00eenceperea tratamentului; \u00eentrerupe\u021bi imediat dac\u0103 apar dureri oculare sau modific\u0103ri ale vederii<\/li>\n<li><strong>Sindromul Stevens-Johnson \/ necroliz\u0103 epidermic\u0103 toxic\u0103<\/strong> \u2014 extrem de rar, dar raportat<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Contraindica\u021bii<\/h2>\n<ul>\n<li>Anurie sau insuficien\u021b\u0103 renal\u0103 sever\u0103 (eGFR &lt;30) \u2014 pierde eficacitate<\/li>\n<li>Hipersensibilitate la sulfonamide (sulfa)<\/li>\n<li>Hiponatremie simptomatic\u0103 (Na &lt;130) sau hipokaliemie (K &lt;3.0) la evaluarea ini\u021bial\u0103<\/li>\n<li>Hipercalcemia<\/li>\n<li>Afectare hepatic\u0103 sever\u0103 (Child-Pugh C)<\/li>\n<li>Boala Addison (insuficien\u021b\u0103 adrenal\u0103 primar\u0103)<\/li>\n<\/ul>\n<p><strong>Sarcina:<\/strong> \u00een general evitate \u2014 tiazidele trec placenta \u0219i pot provoca icter fetal sau neonatal \u0219i trombocitopenie. Utiliza\u021bi numai dac\u0103 beneficiul dep\u0103\u0219e\u0219te clar riscul (hipertensiune rezistent\u0103 \u00een sarcin\u0103 t\u00e2rzie), sub \u00eendrumare specializat\u0103.<\/p>\n<p><strong>Al\u0103ptarea:<\/strong> \u00een general acceptabile la doze mici; dozele mari pot suprima lacta\u021bia (\u00een special tiazidele). Antihipertensive alternative (propranolol, nifedipin\u0103) sunt preferate atunci c\u00e2nd este posibil.<\/p>\n<h2 class=\"wp-block-heading\">Interac\u021biuni medicamentoase<\/h2>\n<ul>\n<li><strong>Litiu \u2014 INTERAC\u021aIUNE CRITIC\u0102.<\/strong> Diureticele tiazidice \u0219i cele de ans\u0103 reduc clearance-ul renal al litiului \u0219i pot precipita toxicitatea acestuia. Evita\u021bi combina\u021bia dac\u0103 este posibil; dac\u0103 este inevitabil, monitoriza\u021bi nivelurile de litiu s\u0103pt\u0103m\u00e2nal \u00een prima lun\u0103 \u0219i reduce\u021bi doza de litiu cu 25-50%.<\/li>\n<li><strong>AINS<\/strong> \u2014 reduc efectul diuretic (prin blocarea prostaglandinelor) \u0219i cresc substan\u021bial riscul de insuficien\u021b\u0103 renal\u0103 acut\u0103 atunci c\u00e2nd sunt combinate cu ACEi\/ARB (\u201ctripla lovitur\u0103\u201d). Utiliza\u021bi paracetamol preferen\u021bial pentru durerea cronic\u0103.<\/li>\n<li><strong>Inhibitori ACE \u0219i ARB<\/strong> \u2014 combina\u021bia este standard \u0219i benefic\u0103 \u00een HTA; ad\u0103ugarea de ACEi\/ARB blocheaz\u0103 activarea compensatorie a sistemului RAAS \u0219i poten\u021beaz\u0103 efectul diuretic. Monitoriza\u021bi potasiul \u0219i creatinina.<\/li>\n<li><strong>Suplimente de potasiu \u0219i diuretice economisitoare de potasiu<\/strong> \u2014 adesea necesare pentru a compensa hipokaliemia indus\u0103 de diureticele de tip loop\/tiazidic. Monitoriza\u021bi potasiul; evita\u021bi corec\u021bia excesiv\u0103.<\/li>\n<li><strong>Digoxin\u0103<\/strong> \u2014 hipokaliemia poten\u021beaz\u0103 toxicitatea digoxinului (diureticele loop \u0219i tiazidice); spironolactona reduce direct clearance-ul digoxinului. Monitoriza\u021bi nivelurile de digoxin \u0219i potasiu la \u00eenceperea sau modificarea diureticului.<\/li>\n<li><strong>Corticoesteroide orale, amfotericina B, laxative stimulante<\/strong> \u2014 hipokaliemie aditiv\u0103 (diuretice loop\/tiazidice) sau necesitate mascat\u0103 de potasiu (spironolacton\u0103).<\/li>\n<li><strong>Antidiabetice orale, insulin\u0103<\/strong> \u2014 diureticele tiazidice \u0219i (\u00een mai mic\u0103 m\u0103sur\u0103) cele loop \u00eenr\u0103ut\u0103\u021besc toleran\u021ba la glucoz\u0103; poate fi necesar\u0103 ajustarea dozei.<\/li>\n<li><strong>Colestiramin\u0103 \/ colestipol<\/strong> \u2014 reduce absorb\u021bia tiazidelor \u0219i a diureticelor de ans\u0103 cu 40-85%. Administrarea trebuie separat\u0103 cu 4 ore.<\/li>\n<li><strong>Alcool<\/strong> \u2014 hipotensiune postural\u0103 aditiv\u0103.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Locul Hyros \u00een clasa diureticelor<\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:14px 0;\">\n<thead>\n<tr style=\"background:#2c7cb0;color:#fff;\">\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">Clas\u0103<\/th>\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">Reprezentan\u021bi<\/th>\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">Utilizare tipic\u0103<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background:#fff3cd;\">\n<td style=\"padding:10px;border:1px solid #ddd;\">Tiazid\u0103<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\"><a href=\"https:\/\/medsbase.com\/ro\/aquazide\/\">HCTZ<\/a>, clortalidon\u0103<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">HTN prim-line, pietre de calciu, DI nefrogen<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:10px;border:1px solid #ddd;\">Asem\u0103n\u0103tor tiazidelor<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\"><a href=\"https:\/\/medsbase.com\/ro\/natrilix-sr\/\">Indapamid\u0103<\/a>, metolazon<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">HTN (v\u00e2rstnici, dovezi HYVET), blocaj secven\u021bial al nefronului<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Diuretic de ans\u0103 (scurt)<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\"><a href=\"https:\/\/medsbase.com\/ro\/lasix\/\">Furosemid\u0103<\/a>, bumetanid\u0103<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Edem pulmonar acut, ICC, ascit\u0103, hipercalcemie<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:10px;border:1px solid #ddd;\">Bucl\u0103 (lung\u0103)<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\"><a href=\"https:\/\/medsbase.com\/ro\/dytor\/\">Torasemid\u0103<\/a><\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">IC cronic\u0103, HTA (singura bucl\u0103 cu dovezi pentru HTA), edem la BCR<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Antagonist de aldosteron\u0103<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\"><a href=\"https:\/\/medsbase.com\/ro\/aldactone\/\">Spironolacton\u0103<\/a>, eplerenon\u0103<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">IC-FER (RALES), HTA rezistent\u0103 (PATHWAY-2), sindrom Conn, ascit\u0103 cirotic\u0103<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:10px;border:1px solid #ddd;\">Alte economizoare de potasiu<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Amilorid\u0103, triamteren (de obicei \u00een combina\u021bii)<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Prevenirea hipokaliemiei atunci c\u00e2nd se adaug\u0103 la bucl\u0103\/tiazidic\u0103<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Anhidraz\u0103 carbonic\u0103<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Acetazolamid\u0103<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Mal de altitudine, glaucom, alcaloz\u0103 metabolic\u0103<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2 class=\"wp-block-heading\">Depozitare<\/h2>\n<p>P\u0103stra\u021bi Hyros la sub 25\u00b0C \u00een ambalajul original blister. \u021aine\u021bi departe de copii.<\/p>\n<h2 id=\"faqs\">\u00centreb\u0103ri frecvente<\/h2>\n<h3 class=\"wp-block-heading\">C\u00e2nd ar trebui s\u0103 iau Hyros \u2014 diminea\u021ba sau seara?<\/h3>\n<p><strong>Diminea\u021ba<\/strong> \u00een aproape toate cazurile. Efectul diuretic produce o cre\u0219tere a produc\u021biei de urin\u0103 timp de 2-4 ore dup\u0103 administrare. Administrarea seara provoac\u0103 nocturie \u0219i perturb\u0103 somnul. Pacien\u021bii care iau diuretice de ans\u0103 de dou\u0103 ori pe zi le administreaz\u0103 de obicei la micul dejun \u0219i la pr\u00e2nz (nu la culcare).<\/p>\n<h3 class=\"wp-block-heading\">Este Hyros un medicament de prim\u0103 linie pentru tensiunea arterial\u0103?<\/h3>\n<p>Da \u2014 tiazidele (HCTZ, clortalidon\u0103) \u0219i agen\u021bii asem\u0103n\u0103tori tiazidelor (indapamida) sunt una dintre <strong>cele patru clase de antihipertensive de prim\u0103 linie<\/strong> al\u0103turi de BRA, inhibitori ACE \u0219i blocante ale canalelor de calciu. Pentru majoritatea pacien\u021bilor cu hipertensiune nou diagnosticat\u0103, o tiazid\u0103 este un agent rezonabil de prim\u0103 sau a doua linie, iar aproape to\u021bi pacien\u021bii afla\u021bi \u00eentr-un regim cu mai multe medicamente includ unul.<\/p>\n<h3 class=\"wp-block-heading\">Va afecta Hyros nivelul meu de potasiu?<\/h3>\n<p>Da \u2014 Hyros <strong>scade<\/strong> potasiul prin cre\u0219terea excre\u021biei de potasiu la nivelul tubului distal. Monitoriza\u021bi la ini\u021biere, dup\u0103 1-2 s\u0103pt\u0103m\u00e2ni \u0219i periodic. Riscul de hipokaliemie este <strong>minimizat prin combinarea<\/strong> Hyros cu un ARB sau inhibitor ACE \u2014 care este combina\u021bia standard \u00een hipertensiune oricum. Dac\u0103 potasiul scade sub 3,5 \u00een utilizarea izolat\u0103 a diureticului, ad\u0103uga\u021bi suplimente de potasiu, o diet\u0103 bogat\u0103 \u00een potasiu sau o doz\u0103 mic\u0103 de un agent care p\u0103streaz\u0103 potasiul (spironolacton\u0103, eplerenon\u0103 sau un <a href=\"https:\/\/medsbase.com\/ro\/amifru\/\">amilorid\u0103<\/a>).<\/p>\n<h3 class=\"wp-block-heading\">Am gut\u0103 \u2014 pot lua Hyros?<\/h3>\n<p>Cu precau\u021bie. Diureticele tiazidice \u0219i (\u00een mai mic\u0103 m\u0103sur\u0103) cele de tip bucl\u0103 cresc acidul uric seric prin competi\u021bia pentru excre\u021bia la nivelul tubului proximal. La pacien\u021bii predispu\u0219i la gut\u0103: prefera\u021bi combina\u021biile pe baz\u0103 de losartan (<a href=\"https:\/\/medsbase.com\/ro\/cosart-h\/\">Cosart H<\/a>, <a href=\"https:\/\/medsbase.com\/ro\/cozartan-h\/\">Cozartan H<\/a>) al c\u0103rui component losartan este unic uricosuric \u0219i contracareaz\u0103 cre\u0219terea uratelor cauzat\u0103 de tiazid\u0103. Dac\u0103 Hyros este deja utilizat \u0219i apar accese de gut\u0103, ad\u0103uga\u021bi sau continua\u021bi terapia de reducere a uratelor (alopurinol) \u00een loc s\u0103 \u00eentrerupe\u021bi Hyros complet.<\/p>\n<h3 class=\"wp-block-heading\">Sunt diabetic \u2014 este Hyros sigur?<\/h3>\n<p>\u00cen mare parte da, dar fi\u021bi con\u0219tient c\u0103 tiazidele \u0219i (\u00eentr-o m\u0103sur\u0103 mai mic\u0103) diureticele de ans\u0103 <strong>\u00eenr\u0103ut\u0103\u021besc modest toleran\u021ba la glucoz\u0103<\/strong> (cre\u0219tere medie a glicemiei \u00een post 5-8 mg\/dL, HbA1c 0,1-0,3%). Beneficiul asupra tensiunii arteriale dep\u0103\u0219e\u0219te acest efect la majoritatea diabeticilor. Dac\u0103 dori\u021bi o combina\u021bie metabolic mai neutr\u0103, ARB+CCB este o alternativ\u0103 (<a href=\"https:\/\/medsbase.com\/ro\/olmezest-am\/\">Olmezest AM<\/a>).<\/p>\n<h3 class=\"wp-block-heading\">Pot lua ibuprofen cu Hyros?<\/h3>\n<p>Utilizarea ocazional\u0103 pe termen scurt este de obicei \u00een regul\u0103. NSAID-urile utilizate zilnic pe termen lung (ibuprofen, diclofenac, naproxen) <strong>reduc efectul diuretic \u0219i antihipertensiv<\/strong> al Hyros (blocarea prostaglandinelor) \u0219i cresc substan\u021bial riscul de AKI atunci c\u00e2nd sunt combinate cu un inhibitor ACE sau ARB \u2014 \u201ctripla lovitur\u0103\u201d. Utiliza\u021bi paracetamol preferen\u021bial pentru durerile cronice.<\/p>\n<h3 class=\"wp-block-heading\">Voi urina mai mult noaptea?<\/h3>\n<p>De obicei nu, dac\u0103 lua\u021bi Hyros diminea\u021ba. Efectul diuretic atinge maximul la 2-4 ore dup\u0103 administrare \u0219i se diminueaz\u0103 \u00een mare parte p\u00e2n\u0103 seara. Nocturia este o pl\u00e2ngere frecvent\u0103 c\u00e2nd pacien\u021bii trec la administrarea seara; reveni\u021bi la administrarea diminea\u021ba \u0219i nocturia se rezolv\u0103 \u00een 1-3 zile.<\/p>\n<h3 class=\"wp-block-heading\">Pot lua Hyros \u00een sarcin\u0103?<\/h3>\n<p>Evitat \u00een mod obi\u0219nuit. Tiazidele trec placenta \u0219i pot afecta f\u0103tul. Pentru hipertensiunea \u00een sarcin\u0103, trece\u021bi la <a href=\"https:\/\/medsbase.com\/ro\/labebet\/\">labetalol<\/a>, metildopa sau nifedipin\u0103. Diureticele sunt utilizate \u00een sarcin\u0103 doar pentru indica\u021bii specifice (edem pulmonar, insuficien\u021b\u0103 cardiac\u0103 rezistent\u0103) sub supraveghere specializat\u0103.<\/p>\n<h3 class=\"wp-block-heading\">Ce fac dac\u0103 uit o doz\u0103?<\/h3>\n<p>Lua\u021bi-l c\u00e2t mai cur\u00e2nd v\u0103 aminti\u021bi, cu excep\u021bia cazului \u00een care este aproape timpul pentru urm\u0103toarea doz\u0103 \u2014 \u00een acest caz omite\u021bi doza ratat\u0103. Nu dubla\u021bi doza. O singur\u0103 doz\u0103 ratat\u0103 nu afecteaz\u0103 semnificativ controlul tensiunii arteriale pe termen lung sau al fluidelor.<\/p>\n<h3 class=\"wp-block-heading\">Unde pot cump\u0103ra Hyros online?<\/h3>\n<p>Pute\u021bi cump\u0103ra Hyros (12,5 \/ 25 mg hidroclorotiazid\u0103, 30-180 comprimate) de la MedsBase cu ambalaj discret \u0219i livrare la nivel mondial.<\/p>\n<h2 class=\"wp-block-heading\">Antihipertensive \u0219i Diuretice Asem\u0103n\u0103toare pe MedsBase<\/h2>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/ro\/aquazide\/\">Aquazide \u2014 Hidroclorotiazid\u0103 (HCTZ) tiazidic\u0103<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/cosart-h\/\">Cosart H \u2014 Losartan + HCTZ combina\u021bie fix\u0103<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/hydrocl\/\">Hydrocl \u2014 Hidroclorotiazid\u0103 (HCTZ)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/losar\/\">Losar \u2014 Losartan (ARB asociat cu diuretic)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/ramcor\/\">Ramcor \u2014 Ramipril (partener ACEi pentru diuretic)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/silectone\/\">Silectone \u2014 Spironolacton\u0103 (antagonist al aldosteronului)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/high-blood-pressure-medication\/\"><strong>R\u0103sfoi\u021bi toate medicamentele pentru hipertensiune arterial\u0103<\/strong><\/a><\/li>\n<\/ul>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:16px 20px;margin:24px 0;border-radius:4px;\"><strong>\u2695 Dezaprobare medical\u0103.<\/strong> Aceast\u0103 pagin\u0103 are scop informativ \u0219i nu \u00eenlocuie\u0219te sfatul medical al unui medic calificat. Hipertensiunea, insuficien\u021ba cardiac\u0103 \u0219i aritmiile necesit\u0103 diagnostic, monitorizare \u0219i individualizarea dozei de c\u0103tre un medic \u2014 utiliza\u021bi \u00eentotdeauna beta-blocante sub \u00eendrumare medical\u0103.<\/div>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h3 class=\"wp-block-heading\">Alternative conexe<\/h3>\n<p>Alte produse din <strong>Afec\u021biuni cronice<\/strong> pe care clien\u021bii le vizualizeaz\u0103 de asemenea:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/ro\/coversyl\/\">Coversyl<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/p-nolol\/\">P-Nolol<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/sazo\/\">Sazo<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/ciplar\/\">Ciplar<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/cort-s-injection\/\">Cort-S Injection<\/a><\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>Hyros este hydrochlorotiazida 12,5\/25 mg de la Zydus Cadila \u2014 un diuretic tiazidic clasic pentru hipertensiune (clasa de prim\u0103 linie), edem \u00een insuficien\u021b\u0103 cardiac\u0103 u\u0219oar\u0103 \u0219i prevenirea recidivei calculilor renali de calciu. Se combin\u0103 bine cu BRA, inhibitori ACE sau blocante ale canalelor de calciu. Doza modern\u0103 este de 12,5-25 mg; doze mai mari ofer\u0103 randamente descresc\u0103toare \u00een reducerea tensiunii arteriale cu efecte metabolice adverse mai accentuate.<\/p>","protected":false},"featured_media":57516,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3141,3223,3260,3356],"product_tag":[3401,4318],"class_list":{"0":"post-57515","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-category-overview","7":"product_cat-chronic-conditions","8":"product_cat-heart-blood-pressure","9":"product_cat-high-blood-pressure-medication","10":"product_tag-hydrochlorothiazide","11":"product_tag-hyros","13":"first","14":"instock","15":"shipping-taxable","16":"purchasable","17":"product-type-variable","18":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product\/57515","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/comments?post=57515"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/media\/57516"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/media?parent=57515"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_brand?post=57515"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_cat?post=57515"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_tag?post=57515"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}